These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38923663)
1. Characterizing Lomerizine metabolites in camel urine: High-resolution mass spectrometry method development and validation for enhanced doping control. Nalakath J; Rasik RP; Kadry A; Babu A; Waseem I; Ok P; Hebel C; Selvapalam N; Nagarajan ER Rapid Commun Mass Spectrom; 2024 Sep; 38(17):e9846. PubMed ID: 38923663 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive metabolite profiling of trimetazidine in camels using high-resolution accurate mass spectrometry: Implications for doping control. Nalakath J; Pt R; Kadry A; Palathinkal AB; Praseen OK; Nelliyott I; Hebel C; Selvapalam N; Nagarajan ER Rapid Commun Mass Spectrom; 2023 Nov; 37(21):e9626. PubMed ID: 37799033 [TBL] [Abstract][Full Text] [Related]
3. Exploring methandienone metabolites generated via homogenized camel liver: Advancements for anti-doping applications through High Resolution-Liquid Chromatography Mass Spectrometry analysis. Vazhat RA; Farook NAM; Nalakath J; Komathu PO Rapid Commun Mass Spectrom; 2024 Dec; 38(22):e9902. PubMed ID: 39226915 [TBL] [Abstract][Full Text] [Related]
4. Analytical detection of trimetazidine produced by metabolic conversion of lomerizine in doping control analysis. Okano M; Thevis M; Sato M; Kageyama S Drug Test Anal; 2016 Aug; 8(8):869-74. PubMed ID: 26560081 [TBL] [Abstract][Full Text] [Related]
5. Lomerizine, trimetazidine and bis-(4-fluorophenyl)-methylpiperazine in human urine after oral administration of lomerizine dihydrochloride: analysis by liquid chromatography-high resolution-tandem mass spectrometry. Okano M; Sato M; Kageyama S Drug Test Anal; 2018 Nov; 10(11-12):1689-1697. PubMed ID: 30240154 [TBL] [Abstract][Full Text] [Related]
6. Investigation of in vitro generated metabolites of LGD-4033, a selective androgen receptor modulator, in homogenized camel liver for anti-doping applications. Ondern Komathu P; Padusha MKSA; Laya S; Nalakath J; Palathinkal AB; Nelliyott I Rapid Commun Mass Spectrom; 2023 Nov; 37(22):e9633. PubMed ID: 37817338 [TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric characterization of urinary hydrafinil metabolites for routine doping control purposes. Knoop A; Fußhöller G; Haenelt N; Goergens C; Guddat S; Geyer H; Thevis M Drug Test Anal; 2021 Nov; 13(11-12):1915-1920. PubMed ID: 34378339 [TBL] [Abstract][Full Text] [Related]
8. Doping control analysis of trimetazidine in dried blood spot. Okano M; Miyamoto A; Ota M; Kageyama S; Sato M Drug Test Anal; 2024 Aug; 16(8):766-776. PubMed ID: 36417202 [TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of the REV-ERB agonist SR-9009 and subsequent detection of metabolites in associated routine equine plasma and urine doping control samples. Cutler C; White DL; Viljanto M Drug Test Anal; 2022 Jan; 14(1):169-174. PubMed ID: 34224639 [TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry. Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032 [TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes. Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457 [TBL] [Abstract][Full Text] [Related]
12. Elimination and phase II metabolism of ethanol in camels after intravenous administration. Wasfi IA; Kamel AM; Saeed HM; Saleh NA; Wajid S; Al Katheeri NA; Agha BA Vet J; 2011 Jul; 189(1):95-9. PubMed ID: 20656536 [TBL] [Abstract][Full Text] [Related]
13. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls. Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680 [TBL] [Abstract][Full Text] [Related]
14. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches. Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825 [TBL] [Abstract][Full Text] [Related]
15. A novel and innovative hair test to determine glucocorticoid levels in racing camels for use in assessment of doping, health, and disease. Shah I; Haddow JD; Ibrahim HA; Sheikh MVA; Alhemeiri FSA Drug Test Anal; 2018 Apr; 10(4):742-749. PubMed ID: 28994213 [TBL] [Abstract][Full Text] [Related]
16. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry. Vonaparti A; Lyris E; Angelis YS; Panderi I; Koupparis M; Tsantili-Kakoulidou A; Peters RJ; Nielen MW; Georgakopoulos C Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1595-609. PubMed ID: 20486255 [TBL] [Abstract][Full Text] [Related]
17. A high-throughput and broad-spectrum screening method for analysing over 120 drugs in horse urine using liquid chromatography-high-resolution mass spectrometry. Wong JKY; Chan GHM; Choi TLS; Kwok KY; Lau MY; Leung GNW; Wan TSM; Ho ENM Drug Test Anal; 2020 Jul; 12(7):900-917. PubMed ID: 32267632 [TBL] [Abstract][Full Text] [Related]
18. Detection of sildenafil and its 9 metabolites in a post-race horse urine sample: A case report. Kabi L E; Zor TA; Göktaş EF; Güneş E; Yatanaslan L; Tektaş MH; İnceman B; Tufan M J Pharm Biomed Anal; 2024 Oct; 249():116343. PubMed ID: 39053097 [TBL] [Abstract][Full Text] [Related]
19. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control. Delcourt V; Garcia P; Chabot B; Loup B; Remy P; Popot MA; Bailly-Chouriberry L Drug Test Anal; 2020 Jun; 12(6):763-770. PubMed ID: 31984676 [TBL] [Abstract][Full Text] [Related]
20. Detection of FG-4592 and metabolites in equine plasma, urine and hair following oral administration. Cutler C; Viljanto M; Taylor P; Hincks P; Habershon-Butcher J; Gray B; Scarth J Drug Test Anal; 2024 Oct; 16(10):1167-1181. PubMed ID: 38217093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]